公司简介

Company Profile

NewScen Coast Bio Pharmaceutical Co., Ltd is a professional manufacturer of in vitro diagnostic products and related supporting apparatuses, which is jointly founded by Tianjin Pharmaceutical Group, Tianjin Zhongxin Pharmaceuticals Co., Ltd and oversea Chinese entrepreneurs. Founded in 2003, the company is one national high tech corporation and Tianjin Grade A medical device manufacturer. Over the years, the company has been committed to the research, development, production and sales of in vitro diagnostic products and related supporting apparatuses, and also has provided OEM and ODM and technology transfer and cooperation as well as some other customermarket based diversified services to customers at home and abroad.
NewScen Coast is based on independent innovation and relies on the talent sharing at home and abroad,information interaction advantage, antibody preparation and new product R & D technology platform to develop and produce nine series about one hundred kinds of products including tests and instruments and put on the market in succession.  HIV (1 + 2) antibody rapid test obtained national patent and national second class of new drug certificate; HCV antibody rapid test is the first double antigen sandwich test HCV patented product; NewScen’s quantitative test broke through the technical difficulty of the colloid gold quantitative detection, opening up a new situation for clinical application of colloidal gold test. Rapid immuno assay reader provides an open and common platform for qualitative and quantitative detection of the colloidal gold test. The company has received CFDA medical device certificates of 32 products, 49 independent intellectual property rights, FDA certificates of 3 products and European CE certificates of 16 products. Production management is in strict accordance with the regulations of in vitro diagnostic product production as well as international quality management system (ISO 9001, ISO 13485) so as to ensure high product quality. Products are sold throughout the country and in North America, South America, Southeast Asia, Europe, the Middle East, Africa and other international markets.

Currently, the company integrated colloidal gold test, immunochromatographic interpretoscope and cloud technology and other technical advantages, and created management integrated POCT system, so as to achieve convenient, accurate and efficient onsite data collection and remote guidance or data sharing of the monitoring center and promote the development of modern testing technique and the improvement of diagnosis and treatment level.

NewScen Coast has obtained the project support from Tianjin or the country for nine times in succession,has been identified as one hightech SME in Tianjin, has obtained the title of “Top 100 SMEs in Tianjin”among Tianjin SMEs, and is the rapid diagnostic  hightech demonstration project base and national 863 project undertaker awarded by the NDRC. Fecal occult blood, serum ferritin and hepatitis C rapid test products were named Tianjin independent innovation products; brand “YBT”products have been awarded the title of “Chinese women and children favorite brand product” by Chinese Women and Children Development Center; “YBT” trademark was named “Tianjin famous trademark”.

Honesty, verity, authenticity, and innovation", is our persistent commitment.

Encouraging our employees growing with company” is the driving force beneath our surging growth.


企业文化

Corporate Culture

企业荣誉

Enterprise Glories

科炬生物历史

NEWSCEN COAST

2020
科炬生物“新型冠状病毒肺炎分层管理检测系统项目” 被中国高科技产业化研究会授牌“高科技产业化推荐项目”
科炬生物“微流控芯片检测COVID-19”抗体项目在 中国创新方法大赛中获得一等奖
天津市科学技术局为科炬生物颁发“天津市科学技术成果登记证书”
2019
被天津市科学技术局认定为“天津市技术领先型企业”
第一条国产微流控自动化生产线落成,取得cTnl,CMC3, PCT注册证书
2018
被天津市科学技术委员会认定为“天津市科技型企业”
被评为“国家高新技术企业”
2014
被认定为“天津市A级放心医疗器械生产企业”
“伊宝泰”产品被中国妇女儿童事业发展中心评为 “中国妇女儿童喜爱的品牌”
入选“中国微生物学会临床微生物专业委员会”重点合作单位
承担国家863项目
构建“互联网+”集成管理式MI-POCT系统
2013
入选“天津市食品药品质量监督管理协会第六届常务理事单位
2012
“伊宝泰”产品被天津市工商行政管理局评为“天津市著名商标”
2011
荣获国家发改委“国家高技术产业化示范工程”荣誉
2010
公司HIV快速检测试剂支持2010年南非世界杯
2009
推出NS3001免疫层析结果判读仪并投产
2007
成功研发HCV双抗原夹心法,引领检测方法变革
2003
中新药业、科炬生物合资成立 “天津中新科炬生物制药股份有限公司”
2002
科炬生物获得国内艾滋病快速诊断试剂二类新药证书
2001
天津科炬生物医学技术有限公司成立 (天津中新科炬生物制药股份有限公司的前身)